By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock (BHST)

NASDAQ Currency in USD
$8.81
+$1.48
+20.17%
Last Update: 12 Sept 2025, 20:00
$152.66M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$4.66 - $9.90
52 Week Range

BHST Stock Price Chart

Explore BioHarvest Sciences Inc. Common Stock interactive price chart. Choose custom timeframes to analyze BHST price movements and trends.

BHST Company Profile

Discover essential business fundamentals and corporate details for BioHarvest Sciences Inc. Common Stock (BHST) to support your stock research and investment decisions.

Sector

Basic Materials

Industry

Agricultural Inputs

IPO Date

Employees

87.00

CEO

Ilan Sobel

Description

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

BHST Financial Timeline

Browse a chronological timeline of BioHarvest Sciences Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 May 2026

Upcoming earnings on 24 Nov 2025

EPS estimate is -$0.14.

Earnings released on 11 Aug 2025

EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%, while revenue for the quarter reached $8.52M , missing expectations by -6.03%.

Earnings released on 15 May 2025

EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%, while revenue for the quarter reached $7.84M , missing expectations by -8.17%.

Earnings released on 31 Mar 2025

EPS came in at -$0.17 falling short of the estimated -$0.12 by -41.67%, while revenue for the quarter reached $7.28M , beating expectations by +0.55%.

Earnings released on 25 Nov 2024

EPS came in at -$0.16 falling short of the estimated -$0.05 by -220.00%, while revenue for the quarter reached $6.54M , missing expectations by -9.66%.

Earnings released on 23 Oct 2024

EPS came in at -$0.04 surpassing the estimated -$0.10 by +57.98%, while revenue for the quarter reached $6.03M , beating expectations by +0.95%.

Earnings released on 31 Mar 2024

EPS came in at -$0.48 , while revenue for the quarter reached $5.34M .

Earnings released on 31 Dec 2023

EPS came in at -$0.54 , while revenue for the quarter reached $4.52M .

Earnings released on 30 Sept 2023

EPS came in at -$0.13 , while revenue for the quarter reached $3.24M .

Earnings released on 30 Jun 2023

EPS came in at -$0.21 , while revenue for the quarter reached $2.75M .

Earnings released on 31 Mar 2023

EPS came in at -$0.06 , while revenue for the quarter reached $2.16M .

Earnings released on 31 Dec 2022

EPS came in at -$0.21 , while revenue for the quarter reached $2.44M .

Earnings released on 30 Sept 2022

EPS came in at -$0.30 , while revenue for the quarter reached $1.52M .

Earnings released on 30 Jun 2022

EPS came in at -$0.18 , while revenue for the quarter reached $838.00K .

Earnings released on 31 Mar 2022

EPS came in at -$0.16 , while revenue for the quarter reached $699.00K .

Earnings released on 31 Dec 2021

EPS came in at -$0.14 , while revenue for the quarter reached $730.00K .

Earnings released on 30 Sept 2021

EPS came in at -$0.25 , while revenue for the quarter reached $644.00K .

Earnings released on 30 Jun 2021

EPS came in at $0.14 , while revenue for the quarter reached $411.48K .

Earnings released on 31 Mar 2021

EPS came in at -$0.56 , while revenue for the quarter reached $315.34K .

Earnings released on 30 Sept 2020

EPS came in at -$0.15 , while revenue for the quarter reached $53.00K .

BHST Stock Performance

Access detailed BHST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run